Medical accountability
The prescriber should be more than a name on a checkout page
A safer peptide therapy process starts with individualized clinical review. For Peptide12-listed options such as semaglutide, tirzepatide, sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu topical foam, and low-dose oral methylene blue, the care team should know the patient’s goal, health history, medication list, allergies, prior side effects, and route-specific risks before treatment is considered.
- Ask who reviews the intake, whether that clinician can practice in the patient’s state, and how questions reach the prescriber after the first decision.
- Ask how the team handles missing records, abnormal labs, medication interactions, pregnancy plans, procedures, side effects, and decisions not to prescribe.
- Avoid any site that turns peptide therapy into no-prescription checkout, automatic approval, influencer protocols, or guaranteed-result packages.